- Home
- UNTY vs AUTL Comparison
UNTY vs AUTL Comparison
Compare UNTY & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UNTY | AUTL |
|---|---|---|
| Founded | 1991 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 523.6M | 433.8M |
| IPO Year | 2014 | 2025 |
Fundamental Metrics
Financial Performance| Metric | UNTY | AUTL |
|---|---|---|
| Price | $53.33 | $1.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $65.00 | $8.50 |
| AVG Volume (30 Days) | 34.4K | ★ 1.4M |
| Earning Date | 04-14-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | N/A | ★ 28.33 |
| EPS | ★ 4.15 | N/A |
| Revenue | N/A | ★ $10,120,000.00 |
| Revenue This Year | $11.57 | $670.78 |
| Revenue Next Year | $8.52 | $80.13 |
| P/E Ratio | $12.83 | ★ N/A |
| Revenue Growth | N/A | ★ 496.00 |
| 52 Week Low | $36.65 | $1.11 |
| 52 Week High | $57.30 | $2.70 |
Technical Indicators
Market Signals| Indicator | UNTY | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 47.67 | 64.61 |
| Support Level | $50.24 | $1.25 |
| Resistance Level | $53.61 | $1.80 |
| Average True Range (ATR) | 1.67 | 0.11 |
| MACD | -0.28 | 0.05 |
| Stochastic Oscillator | 34.81 | 72.50 |
Price Performance
Historical ComparisonAbout UNTY Unity Bancorp Inc.
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.